Novavax’s latecomer Covid-19 vaccine gets U.S. authorization.

Health
By BY REBECCA ROBBINS AND CARL ZIMMER from NYT Health https://ift.tt/R4kW1ra
via IFTTT Vaccination and Immunization, Coronavirus Omicron Variant, Clinical Trials, Coronavirus (2019-nCoV), Factories and Manufacturing, your-feed-healthcare The vaccine was authorized as a primary immunization series for adults, rather than a booster, which may limit its market at first.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda